Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AdaptHealth (AHCO) Operating Expenses (2018 - 2026)

AdaptHealth has reported Operating Expenses over the past 8 years, most recently at $919.9 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 21.21% year-over-year to $919.9 million; the TTM value through Dec 2025 reached $3.2 billion, up 6.32%, while the annual FY2025 figure was $3.2 billion, 6.32% up from the prior year.
  • Operating Expenses for Q4 2025 was $919.9 million at AdaptHealth, up from $758.6 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $1.3 billion in Q3 2023 and troughed at $466.7 million in Q1 2021.
  • A 5-year average of $750.1 million and a median of $742.2 million in 2024 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: surged 154.73% in 2021 and later tumbled 41.32% in 2024.
  • Year by year, Operating Expenses stood at $643.6 million in 2021, then grew by 17.08% to $753.6 million in 2022, then soared by 42.8% to $1.1 billion in 2023, then decreased by 29.47% to $759.0 million in 2024, then grew by 21.21% to $919.9 million in 2025.
  • Business Quant data shows Operating Expenses for AHCO at $919.9 million in Q4 2025, $758.6 million in Q3 2025, and $753.3 million in Q2 2025.